menu search

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions
– 30% risk reduction of MACE-4 composite of death from cardiovascular causes, and >25% risk reduction across four key secondary endpoints in primary prevention population, including 27% reduction in all-cause mortality – – Bempedoic acid is the first LDL-lowering therapy since statins to demonstrate cardiovascular risk reduction in a primary prevention population – – Of the patients […] The post Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes... Read More
Posted: Jun 24 2023, 18:30
Author Name: forextv
Views: 112565

Search within

Pages Search Results: